Downloading...
Download

Atossatherapeutics

ATOS Weekly Shaping UpWe can see that the weekly chart is showing some exhaustion on the sell pressure. The daily has a bit of a heartbeat today breaking over the 20ema/ma. Looking to see the weekly SARs flip underneath to support price, and a break over the T Line (EMA8) on the weekly to confirm a trend change. If there is a solid break, targets (based on current price but will change) would be: Weekly 20ema - 2.04 Weekly 50ema - 2.53 Weekly 100ema - 3.24 Anything over would just be cream. Unless they finally go phase 3 for endoxifen, but I'm sticking to TA.
NASDAQ:ATOSLong
by DrDank
1
ATOS mini TA with fib linesNot surprised that we fell hard after breaking the uptrend (green line) at $8, retested the line at $8.40 to perfection and then fell about 35% to current prices. What surprises me more is that the $5.66 support didn't hold and is now acting as a resistance zone. If we do break this mini resistance, I have no doubt that we will test the $6.60 fib region again. Else, I can see this stock trading between the $4.10 and $5.66 region for a few days/weeks. If it does go lower and hold the 4.10 support I'm a buyer again. Good luck to all holders, I'm sure we all know the potential of this company.
NASDAQ:ATOS
by metalhound
Here We Go (Again?) With ATOSThis is familiar territory with ATOS . Not only is there a very clear and significant support level on the chart, there's also a multi-year level of resistance the ATOS is sitting at right now. The biggest question is Now What? " Earlier this month, Atossa revealed data from a Phase 2 Endoxifen study in breast cancer. It met primary and secondary endpoints. The Phase 2 study was conducted on behalf of Atossa by Avance Clinical, a leading Australian CRO. Based on the results, the company also discussed its plan to apply to the FDA for approval to begin a clinical study in the US 'as soon as possible.' With meaningful results and potential for more clinical trials in the US, ATOS could be on the list of biotech penny stocks on Robinhood to watch this summer ." Quote Source: 7 Penny Stocks On Robinhood To Watch In June 2021
NASDAQ:ATOS
by PennyStocks101
13
ATOS BIG BUY/LONG POTENTIAL 2.65 to 140.00 By Mid 2022!ICKER CODE: ATOS Company Name: ATOSSA THERAPEUTICS, INC Industry: US Stocks Health Technology Medical Specialties Position Proposed: BUY FOMO BUY ENTRY: NOW READY (4.00-5.20) NEXT BUY ENTRY: (2,65 - 3.35) 1st Partial Take Profit: 140.00 (Mid 2022) 2nd Partial Take Profit: 200.00 (Mid 2024) 3RD Partial Take Profit: 320.00 (2027) 1st PARTIAL SHORT TERM TP: 30:200 2nd PARTIAL SHORT TERM TP: 140.00 Stop Loss: 3.00 Technical Analysis 1. FALLING WEDGE PATTERN (COMPLETED ) 2. HEAD & SHOULDERS PATTERN (PARTIALLY COMPLETE) 2. Area of Confluence on EMA & structure level 4. Fibonacci Retracement at 0.618 OR 0.786 5. Safest Take Profit will land 80 % equivalent to the length of head and neckline level 2 of Fibonacci Expansion Blue Zone
NASDAQ:ATOSLong
by traderprosignals
6